Company: HRTX
Filing Date: 2025-09-09
Form Type: PRE 14A
Source: 0000950170-25-113827
Chunk: 7

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-09-09
Form: PRE 14A
Chunk 7
---
 returneachproxy card to ensure that all of your shares are voted.

Can I revoke or change my vote after submitting my proxy?

Yes. You can revoke your proxy and change your vote at any time before the applicable vote deadlines for the Special Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of four ways:

you may submit another properly completed proxy with a later date;

you may vote again by Internet or telephone at a later time;

you may send a written notice that you are revoking your proxy to our Corporate Secretary at 100 Regency Forest Drive, Suite 300, Cary, NC 27518; or

you may attend the Special Meeting and vote electronically during the Special Meeting (however, simply attending the Special Meeting will not, by itself, revoke your proxy or change your vote).

Your most current proxy card or Internet proxy is the one that is counted.

If you hold your shares beneficially in street name, you may change your vote by submitting new voting instructions to your bank, broker or nominee following the instructions they provide.

What are “broker non-votes”?

If your shares are held by your broker, bank or other agent (that is, in “street name”), you will need to obtain a proxy form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your broker, bank or other agent to vote your shares. If a beneficial owner of shares held in “street name” does not give instructions to his or her broker, bank or other agent, such nominee has discretionary authority to vote such shares with respect to “routine” matters but does not have discretionary authority to vote such shares with respect to “non-routine” matters. For “non-routine” matters for which a broker, bank or other agent does not have discretionary authority to vote a beneficial owner’s shares, the un-voted shares are generally referred to and counted as “broker non-votes.” The determination of whether a proposal is “routine” or “non-routine” is made pursuant to applicable stock exchange rules.

The approval of the issuance of shares of the Company’s Common Stock upon the conversion of convertible senior unsecured promissory notes due 2031 (“Proposal 1”) and the approval of the issuance of shares of the Company’s Common Stock upon the conversion of the Company’s Series A Convertible Preferred Stock (“Proposal 2”) are considered as “non-routine” matters under applicable rules. We therefore expect broker non-votes to exist